Inhaled Nitric Oxide Enables Artificial Blood Transfusion Without Hypertension
Author(s) -
Binglan Yu,
Michael J. Raher,
Gian Paolo Volpato,
Kenneth D. Bloch,
Fumito Ichinose,
Warren M. Zapol
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.729137
Subject(s) - medicine , vasoconstriction , hemoglobin , methemoglobin , nitric oxide , hypoxic pulmonary vasoconstriction , anesthesia , methemoglobinemia , pulmonary hypertension , pharmacology , systemic administration , nitric oxide synthase , biology , microbiology and biotechnology , in vivo
One of the major obstacles hindering the clinical development of a cell-free, hemoglobin-based oxygen carrier (HBOC) is systemic vasoconstriction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom